People In The News | GenomeWeb

NEW YORK (GenomeWeb) – St. Jude Children's Research Hospital has appointed James Downing as its new CEO, effective July 15. Downing most recently served as deputy director, executive vice president, and scientific director of the hospital. He will succeed William Evans, who is retiring as CEO after 10 years and returning full time to his pharmacogenomics research program at St. Jude.

EpiCypher, an epigenomics products and services firm, has named Sam Tetlow to be its first CEO and to serve on the board of directors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.